BRCA1 rs1799966: Understanding This Genetic Variant
The rs1799966 variant is a specific change located within the BRCA1 gene. It has been studied for its potential role in contributing to a slightly increased risk for breast cancer as part of a broader genetic risk profile.
What each genotype means
Typical risk profile
This genotype represents the most common form of this variant observed in many populations. Research suggests this version does not contribute to the slightly increased breast cancer risk associated with the G allele in this multi-SNP profile.
This is the most common genotype for this variant globally.
Slightly increased risk
Carrying one copy of the G allele is associated with a very slightly increased risk for breast cancer as part of a broader multi-SNP risk profile. This association is based on limited evidence and should be viewed as a small contributor to overall risk rather than a diagnostic indicator.
This heterozygous genotype is common, reflecting the variant's overall minor allele frequency of approximately 0.3274.
Slightly increased risk
Carrying two copies of the G allele is associated with a very slightly increased risk for breast cancer within the context of a multi-SNP risk profile. As with the heterozygous state, the evidence for this association is limited, and it represents only a minor component of overall breast cancer susceptibility.
This genotype occurs at a frequency consistent with the reported minor allele frequency of 0.3274.
What is the rs1799966 Variant?
The rs1799966 variant is a single nucleotide polymorphism (SNP) located within the BRCA1 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is cataloged in international databases that track genetic diversity and its potential health implications. While many variants in the human genome are benign and have no observable effect on health, researchers monitor specific sites like rs1799966 to determine if they correlate with complex traits or disease susceptibility. Because this variant is located in a gene well-known for its role in DNA repair, it has been a subject of interest in studies investigating hereditary cancer-predisposing syndromes. However, it is important to distinguish between this common variant and the rare, highly penetrant mutations in BRCA1 that are known to cause significant increases in cancer risk.
The Role of the BRCA1 Gene
The BRCA1 gene provides instructions for making a protein that acts as a tumor suppressor. This protein is essential for maintaining genomic stability by repairing damaged DNA, particularly double-strand breaks. When the BRCA1 protein functions correctly, it helps prevent cells from growing and dividing too rapidly or in an uncontrolled way. Inherited mutations in BRCA1 are famously associated with a significantly increased risk of developing breast and ovarian cancers. However, the gene is large and contains many different variants. While some variants completely disrupt the protein's function, others, like rs1799966, are much more subtle. These common variants are often investigated to see if they contribute to the 'polygenic' risk of cancer—meaning they might exert a very small influence on risk when combined with many other genetic factors and environmental exposures, rather than acting as a primary cause of disease on their own.
Research and Evidence Strength
Current research into rs1799966 characterizes the evidence for its association with breast cancer as limited. Scientific studies, including those utilizing logistic regression to estimate odds ratios, have explored whether this variant correlates with cancer risk in specific populations, such as in recent studies involving Nigerian women. Because the evidence is limited, it is not considered a definitive diagnostic marker. Instead, it is viewed as a potential contributor to a multi-SNP risk profile. In genomics, a multi-SNP profile aggregates the effects of many small-effect variants to provide a more comprehensive view of genetic predisposition. Because these associations can vary significantly based on ancestry and environmental factors, findings in one population may not necessarily apply to others. Consequently, the scientific community continues to gather data to better understand the clinical relevance of this variant, emphasizing that it should not be interpreted in isolation.
Population Frequency
The frequency of the rs1799966 variant varies across different global populations. Genetic databases often report a Global Minor Allele Frequency (GMAF) of approximately 0.3274, indicating that the variant is relatively common in the general population. Because it is found at such a high frequency, it is considered a common polymorphism rather than a rare, pathogenic mutation. Understanding these frequency patterns is crucial for researchers, as it helps them determine whether a variant is likely to be a neutral part of human diversity or a factor that influences disease risk. When a variant is this common, it suggests that it has been present in the human gene pool for a long time. Researchers use this frequency data to calibrate their statistical models, ensuring that they can accurately distinguish between common genetic background noise and genuine signals of disease association.
Interpreting Your Genetic Information
If you have received information about your rs1799966 genotype, it is important to understand that this result does not constitute a medical diagnosis. Genetic variants like this are typically studied in the context of large population-wide research, and their individual impact on your personal health is likely negligible. You cannot use this information to predict your future health outcomes or to make medical decisions. If you are concerned about your family history of cancer or your personal risk profile, the most appropriate step is to consult with a certified genetic counselor or a healthcare provider. They can evaluate your entire clinical picture, including your family history and other risk factors, which are far more predictive of health outcomes than any single SNP. Always discuss any health concerns with a professional who can provide context and guidance tailored to your specific needs.
How common is this variant?
The rs1799966 variant is common, with a reported Global Minor Allele Frequency (GMAF) of 0.3274 across diverse populations.
Frequently asked questions
Does having the rs1799966 variant mean I have a BRCA1 mutation?
While rs1799966 is located in the BRCA1 gene, it is a common variant and is distinct from the rare, high-risk mutations that are typically referred to in clinical settings as 'BRCA mutations.' It does not carry the same high-risk implications as those specific pathogenic variants.
Can I use this SNP to predict my breast cancer risk?
No, this SNP cannot be used to predict your individual risk of breast cancer. It is only one of many factors, and its individual contribution to risk is considered very small and currently limited by scientific evidence.
Should I get a clinical test for this variant?
Clinical testing for this specific SNP is generally not recommended for individual health management. If you have concerns about cancer risk, speak with a genetic counselor about comprehensive risk assessment.
Where can I find more information about BRCA1?
You can find reliable, educational information about the BRCA1 gene and its role in health on the MedlinePlus Genetics website. It provides clear summaries of how genes function and their relationship to various health conditions.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1799966?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BRCA1
This rare variant has been recently annotated in clinical databases as a potential contributor to hereditary breast and ovarian cancer risk.
Variant identified in polygenic risk scores for breast cancer susceptibility.
A rare variant located in the BRCA1 gene, relevant to reproductive genetic counseling and the assessment of hereditary cancer risk.
This variant is a rare genetic alteration in the BRCA1 gene, which is critical for DNA repair and associated with hereditary breast and ovarian cancer syndromes impacting reproductive health.
A very rare variant identified in recent genomic studies, currently being investigated for potential associations with reproductive phenotypes.
A common BRCA1 variant (p.Ser1613Gly) often included in polygenic risk scores for breast cancer, but not classified as a pathogenic mutation for hereditary cancer syndromes.